Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Short-term Investments (2020 - 2025)

RxSight (RXST) has disclosed Short-term Investments for 6 consecutive years, with $208.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 5.6% year-over-year to $208.2 million, compared with a TTM value of $208.2 million through Dec 2025, down 5.6%, and an annual FY2025 reading of $208.2 million, down 5.6% over the prior year.
  • Short-term Investments was $208.2 million for Q4 2025 at RxSight, up from $197.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $220.5 million in Q4 2024 and bottomed at $20.0 million in Q2 2021.
  • Average Short-term Investments over 5 years is $143.9 million, with a median of $135.0 million recorded in 2021.
  • The sharpest move saw Short-term Investments skyrocketed 423.13% in 2022, then tumbled 35.14% in 2024.
  • Year by year, Short-term Investments stood at $135.0 million in 2021, then tumbled by 30.38% to $94.0 million in 2022, then increased by 25.03% to $117.5 million in 2023, then soared by 87.69% to $220.5 million in 2024, then dropped by 5.6% to $208.2 million in 2025.
  • Business Quant data shows Short-term Investments for RXST at $208.2 million in Q4 2025, $197.9 million in Q3 2025, and $187.1 million in Q2 2025.